Matthew Holsti

Matthew Holsti is a seasoned Associate Research Fellow with over 15 years of experience in monoclonal antibody generation. Currently, they serve as the Group Lead for the Endogenous Antibody Discovery Group in the BioMedicine Design department at Pfizer, where they have extensive hands-on experience with hybridoma generation and microfluidics-based discovery platforms. Prior to this, Holsti worked as a Research Scientist at Dana-Farber Cancer Institute from 2005 to 2010. They hold an education background from the Massachusetts Institute of Technology, which they attended from 1986 to 1992.